In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

These findings could lead to advancements in lung cancer treatments by helping doctors select better T cells for therapy using gene editing and developing ways to reintroduce the missing antigens ...

Dubai, United Arab Emirates — Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, may be ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...

Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.

In India, two cancer patients treated with CAR T therapy have survived three years in one of the longest follow-ups in South ...

CLOVIS, Calif. (KFSN) -- For the first time, a potential cancer cure is being offered here in Central California. Action News ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...

The cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...